Dasatinib Combined With Chemotherapy in Relapsed t(8;21) Acute Myeloid Leukemia With KIT D816 Mutation
Clinical trial NCT03560908 · WITHDRAWN
Trial details
- NCT number
- NCT03560908
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-01
- Primary completion
- 2020-12-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.